🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 10/15/2026 · $16.00/unit
Business: Iambic Therapeutics, Inc. is a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform The Company's Platform platform is designed to address the totality of drug discovery and development by integrating proprietary AI with automated, scalable chemistry and biology experimentation.
Company Contact
- CEO
- Thomas Miller
- CFO
- Michael Secora
- Headquarters
- 5627 Oberlin Drive, Suite 120, San Diego, CA 92121
- Phone
- 626-592-2520
- Investor Relations
- Tiao Guan · tiao.guan@iambic.ai